VII

New AMD Radeon PRO W6000 Series Graphics Unleash High-Efficiency, Powerful CAD Performance for Mainstream Workstation Users

Retrieved on: 
Wednesday, January 19, 2022 - 2:00pm

SANTA CLARA, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Today AMD (NASDAQ: AMD) announced new additions to the AMD Radeon™ PRO W6000 Series desktop and mobile workstation graphics lineup, designed to deliver exceptional performance, stability and reliability for professional users, including CAD designers, engineers and office knowledge workers.

Key Points: 
  • AMD Radeon PRO W6500M and Radeon PRO W6300M GPUs are expected to be available in pre-built OEM systemsinselect countries later this year.
  • Testing conducted by AMD Performance Labs as of December 17, 2021 on a test system comprising Intel XeonW-2125 (Skylake-W) at 4Ghz, Windows 10 Pro, and AMD Radeon PRO W6400 GPU pre-production sample / AMD Radeon PRO WX 3200 GPU with AMD Driver 21.40 RC.
  • Testing as of March 23, 2021 by AMD Performance Labs on a test system comprised of an AMD Ryzen 5950X with AMD Radeon PRO W5700, AMD Radeon PRO W6800, AMD Radeon PRO WX 9100.
  • Compatible with AMD Radeon Pro WX 2100, 3100, 3200, 4100, 5100, 7100, 8200, 9100, and AMD Radeon Pro W5500, W5700, W6600, W6800 and VII GPUs.

Technological Revolution and Industrial Transformation, Weichai Power Releases the World's First Diesel Engine with a Base Engine Thermal Efficiency of 51.09%, along with Major Hydrogen Energy Technology Achievements

Retrieved on: 
Thursday, January 13, 2022 - 9:45am

TuV SuD, an world-renowned test authority, issued a certificate of thermal efficiency of 51.09% to Weichai Power.

Key Points: 
  • TuV SuD, an world-renowned test authority, issued a certificate of thermal efficiency of 51.09% to Weichai Power.
  • Transportation is an important field for this target, and the internal combustion engine industry plays an important role in this process.
  • Thermal efficiency is the yardstick for the fuel efficiency of internal combustion engines: higher thermal efficiency represents lower fuel consumption and better effects of energy conservation and emission reduction.
  • Improving thermal efficiency has been the common pursuit of the global diesel engine industry since diesel engines emerged 125 years ago.

CTIA Launches 5G Security Test Bed for Commercial 5G Networks

Retrieved on: 
Wednesday, January 12, 2022 - 4:30pm

WASHINGTON, Jan. 12, 2022 /PRNewswire/ --CTIA today announced the launch of its 5G Security Test Bed (STB), a security testing and validation initiative dedicated to commercial 5G networks.

Key Points: 
  • WASHINGTON, Jan. 12, 2022 /PRNewswire/ --CTIA today announced the launch of its 5G Security Test Bed (STB), a security testing and validation initiative dedicated to commercial 5G networks.
  • CTIA created the STB in partnership with organizations across wireless, tech, and academia to test 5G security recommendations across real-world conditions using commercial-grade equipment and facilities.
  • The 5G Security Test Bed's founding membersAT&T, Ericsson, T-Mobile, UScellular, MITRE, and the University of Maryland (UMD)contribute invaluable industry expertise that strengthens the STB's ability to enhance the wireless security ecosystem and ensure strong protections on 5G networks.
  • We're thrilled that the 5G Security Test Bed will provide an environment to assess potential threats to 5G security raised by security researchers."

Technological Revolution and Industrial Transformation

Retrieved on: 
Tuesday, January 11, 2022 - 5:36pm

Then the delivery ceremony of hydrogen-powered heavy-duty truck delivery for demonstrative operation between Shandong Heavy Industry and Shandong Port was held.

Key Points: 
  • Then the delivery ceremony of hydrogen-powered heavy-duty truck delivery for demonstrative operation between Shandong Heavy Industry and Shandong Port was held.
  • Transportation is an important field for this target, and the internal combustion engine industry plays an important role in this process.
  • The base engine thermal efficiency of 51.09% is another significant revolution of traditional engines, as well as a technical preparation for the implementation of the "China VII" emission standard.
  • A series of outcomes marks that the "Hydrogen for Every Home" technology demonstration project is turning from blueprint into reality.

Bioceres Crop Solutions Subsidiary Rizobacter Completes $20 Million Offering of Series VII Corporate Bonds

Retrieved on: 
Thursday, December 23, 2021 - 1:31pm

Bioceres Crop Solutions Corp. (Bioceres or the Company) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that its subsidiary Rizobacter Argentina S.A. (Rizobacter) has completed a $20 million public offering of Series VII corporate bonds in the Argentine market.

Key Points: 
  • Bioceres Crop Solutions Corp. (Bioceres or the Company) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that its subsidiary Rizobacter Argentina S.A. (Rizobacter) has completed a $20 million public offering of Series VII corporate bonds in the Argentine market.
  • About Bioceres Crop Solutions Corp.
    Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality.
  • To do this, Bioceres solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices.
  • The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions.

Miami Dolphins Enhance Fan Experience, Safety and Security at Hard Rock Stadium with Dell Technologies

Retrieved on: 
Wednesday, December 15, 2021 - 2:00pm

"We're posting video content of all entertainment content captured at Hard Rock Stadium much faster while helping build excitement and engagement with our fans,"said Kim Rometo, vice president and chief information officer, the Miami Dolphins and Hard Rock Stadium.

Key Points: 
  • "We're posting video content of all entertainment content captured at Hard Rock Stadium much faster while helping build excitement and engagement with our fans,"said Kim Rometo, vice president and chief information officer, the Miami Dolphins and Hard Rock Stadium.
  • "With Dell Technologies infrastructure, the Miami Dolphins are bringing the fan experience to a new level while transforming IT operations," said John Byrne, president of North America Sales, Dell Technologies.
  • Today, Dell Technologies three-petabyte infrastructure sets the technology foundation for Hard Rock Stadium, the Miami Dolphins training camp data centers and a new colocation backup facility.
  • Dell Technologies, Dell, EMC and Dell EMC are trademarks of Dell Inc. or its subsidiaries.

Onconova Therapeutics Announces the Presentation of Preliminary Clinical Data Providing Evidence of Rigosertib’s Activity in RDEB-associated Squamous Cell Carcinoma

Retrieved on: 
Thursday, December 2, 2021 - 1:00pm

Over time, many of these patients develop squamous cell carcinomas (SCCs) that typically arise in areas of chronic skin wounding and inflammation.

Key Points: 
  • Over time, many of these patients develop squamous cell carcinomas (SCCs) that typically arise in areas of chronic skin wounding and inflammation.
  • Data from the recent presentation are from a 24-year-old RDEB patient with a history of multiple, unresectable SCCs that were unresponsive to prior treatments including cemiplimab.
  • Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer.
  • The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Krystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK™ in Patients with Dystrophic Epidermolysis Bullosa

Retrieved on: 
Monday, November 29, 2021 - 12:00pm

PITTSBURGH, Nov. 29, 2021 (GLOBE NEWSWIRE) --  Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced positive topline results from the pivotal GEM-3 trial of investigational beremagene geperpavec (B-VEC), now known as VYJUVEKTM, for the treatment of dystrophic Epidermolysis Bullosa (dystrophic EB).

Key Points: 
  • Todays positive B-VEC results represent the culmination of years of study on the molecular basis and genetic correction of this disease.
  • Finally, dystrophic EB patients may have an easily administered genetically targeted therapy which has been shown to promote durable wound healing in this clinical trial.
  • We founded Krystal less than six years ago with the goal of developing a non-invasive, genetically corrective therapy for dystrophic EB.
  • ET, to discuss topline results from the pivotal GEM-3 trial and the VYJUVEKTM program.

Broxel Presents The New Miami Dolphins Card

Retrieved on: 
Thursday, November 25, 2021 - 6:20pm

MIAMI GARDENS, Nov. 25, 2021 /PRNewswire/ --Broxel, a global leader in payment methods to achieve a barrier-free economy has announced that they have joined forces with the Miami Dolphins to create a branded debit card.

Key Points: 
  • MIAMI GARDENS, Nov. 25, 2021 /PRNewswire/ --Broxel, a global leader in payment methods to achieve a barrier-free economy has announced that they have joined forces with the Miami Dolphins to create a branded debit card.
  • "We are excited about expanding our cashless experience with Broxel," said Jeremy Walls, Senior Vice President, Chief Revenue Officer of Miami Dolphins.
  • The new Dolphins card offers next generation functionalities through the Broxel app including the chance for every user to actively participate in the development of new capabilities.
  • The Dolphins play home games at Hard Rock Stadium and train at the Baptist Health Training Complex in Miami Gardens.

Abeona Therapeutics Announces Support of EB Research Partnership's Venture Into Cures Event to Raise Awareness for Education and Research of Epidermolysis Bullosa

Retrieved on: 
Thursday, November 18, 2021 - 12:30pm

The event will take place virtually on November 18, 2021 at 8:00 p.m. ET/ 5:00 p.m. PT.

Key Points: 
  • The event will take place virtually on November 18, 2021 at 8:00 p.m. ET/ 5:00 p.m. PT.
  • We are thankful for the opportunity to continue collaborating with EB Research Partnership and are excited to support this important event, said Vish Seshadri, Ph.D., M.B.A., Chief Executive Officer of Abeona.
  • Venture Into Cures provides the general public with an engaging opportunity to learn about this devastating disease and shines a light on the urgent unmet medical need the EB community faces.
  • We are working with urgency to meet this need by investigating EB-101, an innovative treatment for patients with recessive dystrophic epidermolysis bullosa, the most severe form of EB.